27445435|t|Elevated Plasma Level of Interferon-λ1 in Chronic Spontaneous Urticaria: Upregulated Expression in CD8(+) and Epithelial Cells and Induction of Inflammatory Cell Accumulation
27445435|a|Interferon- (IFN-) λ1 is regarded as a potent bio-active molecule in innate immunity. However, little is known about its role in chronic spontaneous urticaria (CSU). We therefore investigated expression of IFN-λ1 in CSU, its cellular location, and its influence on inflammatory cell accumulation by using flow cytometry analysis, skin tissue dispersion, immunohistochemical stain, and a mouse peritoneal inflammation model. The results showed that level of IFN-λ1 was 2.0-fold higher in plasma of the patients with CSU than the level in healthy control (HC) subjects. Among leukocytes examined, only CD8(+) T cells expressed more IFN-λ1 in CSU blood. Double labeling immunohistochemical staining revealed that IFN-λ1 (+) inflammatory cells such as mast cells, eosinophils, B cells, neutrophils, and macrophages were mainly located in dermis, whereas epidermis tissue highly expressed IFN-λ1. IFN-λ1 induced a dose-dependent increase in number of eosinophils, lymphocytes, mast cells, macrophages, and neutrophils in the peritoneum of mice at 6 h following injection, which was inhibited by pretreatment of the animals with anti-intercellular adhesion molecule- (ICAM-) 1 and/or anti-L-selectin antibodies. In conclusion, IFN-λ1 is likely to play a role in the pathogenesis of CSU. Blocking IFN-λ1 production may help to reduce the accumulation of inflammatory cells in the involved CSU skin.
27445435	0	8	Elevated	T080	C3163633
27445435	9	15	Plasma	T031	C0032105
27445435	16	21	Level	T080	C0441889
27445435	25	38	Interferon-λ1	T116,T129	C3541295
27445435	42	71	Chronic Spontaneous Urticaria	T047	C0578870
27445435	73	84	Upregulated	T044	C0041904
27445435	85	95	Expression	T045	C1171362
27445435	99	105	CD8(+)	T025	C0242629
27445435	110	126	Epithelial Cells	T025	C0014597
27445435	131	140	Induction	T169	C0205263
27445435	144	161	Inflammatory Cell	T025	C0440752
27445435	162	174	Accumulation	T033	C4055506
27445435	175	196	Interferon- (IFN-) λ1	T116,T129	C3541295
27445435	221	240	bio-active molecule	T167	C3714412
27445435	244	259	innate immunity	T032	C0020969
27445435	304	333	chronic spontaneous urticaria	T047	C0578870
27445435	335	338	CSU	T047	C0578870
27445435	354	366	investigated	T169	C1292732
27445435	367	377	expression	T045	C1171362
27445435	381	387	IFN-λ1	T116,T129	C3541295
27445435	391	394	CSU	T047	C0578870
27445435	400	417	cellular location	T026	C1268228
27445435	440	457	inflammatory cell	T025	C0440752
27445435	458	470	accumulation	T033	C4055506
27445435	480	503	flow cytometry analysis	T059	C0016263
27445435	505	516	skin tissue	T024	C0684084
27445435	517	527	dispersion	T082	C0332624
27445435	529	554	immunohistochemical stain	T059	C1508788
27445435	562	567	mouse	T015	C0026809
27445435	568	591	peritoneal inflammation	T046	C0031154
27445435	592	597	model	T050	C2986594
27445435	632	638	IFN-λ1	T116,T129	C3541295
27445435	652	658	higher	T080	C0205250
27445435	662	668	plasma	T031	C0032105
27445435	676	684	patients	T101	C0030705
27445435	690	693	CSU	T047	C0578870
27445435	703	708	level	T080	C0441889
27445435	712	727	healthy control	T080	C2986479
27445435	729	731	HC	T080	C2986479
27445435	733	741	subjects	T098	C0080105
27445435	749	759	leukocytes	T025	C0023516
27445435	775	789	CD8(+) T cells	T025	C0242629
27445435	790	799	expressed	T045	C1171362
27445435	805	811	IFN-λ1	T116,T129	C3541295
27445435	815	818	CSU	T047	C0578870
27445435	819	824	blood	T031	C0005768
27445435	826	870	Double labeling immunohistochemical staining	T059	C1508788
27445435	885	891	IFN-λ1	T116,T129	C3541295
27445435	896	914	inflammatory cells	T025	C0440752
27445435	923	933	mast cells	T025	C0024880
27445435	935	946	eosinophils	T025	C0014467
27445435	948	955	B cells	T025	C0004561
27445435	957	968	neutrophils	T025	C0027950
27445435	974	985	macrophages	T025	C0024432
27445435	998	1005	located	T029	C1515974
27445435	1009	1015	dermis	T024	C0011646
27445435	1025	1041	epidermis tissue	T024	C0014520
27445435	1049	1058	expressed	T045	C1171362
27445435	1059	1065	IFN-λ1	T116,T129	C3541295
27445435	1067	1073	IFN-λ1	T116,T129	C3541295
27445435	1074	1081	induced	T169	C0205263
27445435	1084	1098	dose-dependent	T081	C1512045
27445435	1099	1107	increase	T081	C0205217
27445435	1121	1132	eosinophils	T025	C0014467
27445435	1134	1145	lymphocytes	T025	C0024264
27445435	1147	1157	mast cells	T025	C0024880
27445435	1159	1170	macrophages	T025	C0024432
27445435	1176	1187	neutrophils	T025	C0027950
27445435	1195	1205	peritoneum	T024	C0031153
27445435	1209	1213	mice	T015	C0026809
27445435	1231	1240	injection	T122	C1272883
27445435	1252	1261	inhibited	T080	C0311403
27445435	1265	1277	pretreatment	T052	C3539076
27445435	1285	1292	animals	T008	C0003062
27445435	1298	1345	anti-intercellular adhesion molecule- (ICAM-) 1	T116,T129	C0063695
27445435	1353	1379	anti-L-selectin antibodies	T116,T129	C0003241
27445435	1396	1402	IFN-λ1	T116,T129	C3541295
27445435	1435	1447	pathogenesis	T046	C0699748
27445435	1451	1454	CSU	T047	C0578870
27445435	1456	1464	Blocking	T169	C0332206
27445435	1465	1471	IFN-λ1	T116,T129	C3541295
27445435	1472	1482	production	T169	C1522492
27445435	1495	1501	reduce	T080	C0392756
27445435	1506	1518	accumulation	T033	C4055506
27445435	1522	1540	inflammatory cells	T025	C0440752
27445435	1557	1560	CSU	T047	C0578870
27445435	1561	1565	skin	T022	C1123023